Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID-19) is determined by the presence of cytokine storm

被引：7
作者：
Andrianopoulos, Ioannis [1 ]
Papathanasiou, Athanasios [1 ]
Papathanakos, Georgios [1 ]
Chaidos, Aristeidis [2 ]
Koulouras, Vasilios [1 ]
机构：
[1] Univ Hosp Ioannina, Intens Care Unit, Stavros Niarchos Ave, Ioannina 45500, Greece
[2] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 01期
关键词：
D O I：
10.1002/jmv.26209
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 12 条
  • [1] Borku Uysal B, 2020, J MED VIROL, DOI [10.1002/jmv.26111, DOI 10.1002/JMV.26111]
  • [2] Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
    Capra, Ruggero
    De Rossi, Nicola
    Mattioli, Flavia
    Romanelli, Giuseppe
    Scarpazza, Cristina
    Sormani, Maria Pia
    Cossi, Stefania
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 76 : 31 - 35
  • [3] Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
    Colaneri, Marta
    Bogliolo, Laura
    Valsecchi, Pietro
    Sacchi, Paolo
    Zuccaro, Valentina
    Brandolino, Fabio
    Montecucco, Carlomaurizio
    Mojoli, Francesco
    Giusti, Emanuele Maria
    Bruno, Raffaele
    [J]. MICROORGANISMS, 2020, 8 (05)
  • [4] Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
    Giamarellos-Bourboulis, Evangelos J.
    Netea, Mihai G.
    Rovina, Nikoletta
    Akinosoglou, Karolina
    Antoniadou, Anastasia
    Antonakos, Nikolaos
    Damoraki, Georgia
    Gkavogianni, Theologia
    Adami, Maria-Evangelia
    Katsaounou, Paraskevi
    Ntaganou, Maria
    Kyriakopoulou, Magdalini
    Dimopoulos, George
    Koutsodimitropoulos, Ioannis
    Velissaris, Dimitrios
    Koufargyris, Panagiotis
    Karageorgos, Athanassios
    Katrini, Konstantina
    Lekakis, Vasileios
    Lupse, Mihaela
    Kotsaki, Antigone
    Renieris, George
    Theodoulou, Danai
    Panou, Vassiliki
    Koukaki, Evangelia
    Koulouris, Nikolaos
    Gogos, Charalambos
    Koutsoukou, Antonia
    [J]. CELL HOST & MICROBE, 2020, 27 (06) : 992 - +
  • [5] Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
    Klopfenstein, T.
    Zayet, S.
    Lohse, A.
    Balblanc, J-C
    Badie, J.
    Royer, P-Y
    Toko, L.
    Mezher, C.
    Kadiane-Oussou, N. J.
    Bossert, M.
    Bozgan, A-M
    Charpentier, A.
    Roux, M-F
    Contreras, R.
    Mazurier, I
    Dussert, P.
    Gendrin, V
    Conrozier, T.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (05): : 397 - 400
  • [6] Tocilizumab treatment in COVID-19: A single center experience
    Luo, Pan
    Liu, Yi
    Qiu, Lin
    Liu, Xiulan
    Liu, Dong
    Li, Juan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) : 814 - 818
  • [7] COVID-19: consider cytokine storm syndromes and immunosuppression
    Mehta, Puja
    McAuley, Daniel F.
    Brown, Michael
    Sanchez, Emilie
    Tattersall, Rachel S.
    Manson, Jessica J.
    [J]. LANCET, 2020, 395 (10229) : 1033 - 1034
  • [8] Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
    Netea, Mihai G.
    Giamarellos-Bourboulis, Evangelos J.
    Dominguez-Andres, Jorge
    Curtis, Nigel
    van Crevel, Reinout
    van de Veerdonk, Frank L.
    Bonten, Marc
    [J]. CELL, 2020, 181 (05) : 969 - 977
  • [9] Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
    Richardson, Safiya
    Hirsch, Jamie S.
    Narasimhan, Mangala
    Crawford, James M.
    McGinn, Thomas
    Davidson, Karina W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 2052 - 2059
  • [10] Sakpal Tushar Vijay, 2010, Perspect Clin Res, V1, P67
12